Chile vs Europe and Northern America: Proportion of the target population who received the final dose of
Chile
87.0%
in 2024
Europe and Northern America
46.0%
in 2024
Chile rank
16th
Europe and Northern America rank
16th
Proportion of the target population who received the final dose of over time
- Chile
- Europe and Northern America
How they compare
Chile currently reports 87.0% against 46.0% in Europe and Northern America, a difference of 41.0%.
That makes Chile's figure about 1.9 times Europe and Northern America's.
Across all 10 years both countries report, Chile has been ahead every year.
Chile ranks 16th and Europe and Northern America ranks 16th of 107 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Europe and Northern America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.8% | 37.0% | 40.8% | Chile |
| 2020s | 74.6% | 43.6% | 31.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Chile or Europe and Northern America?
- Chile, at 87.0% against 46.0% in Europe and Northern America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Chile and Europe and Northern America?
- 41.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Europe and Northern America?
- 10 years are reported by both, from 2015 to 2024.
- How do Chile and Europe and Northern America rank globally for proportion of the target population who received the final dose of?
- Chile ranks 16th and Europe and Northern America ranks 16th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.